Table 2. 18F-FSPG and 18F-FDG evaluation of primary lesion.
IPNs (7-30mm) | Mass (>30mm) | ||
---|---|---|---|
Malignant (N = 12) | Benign (N = 9) | Malignant (N = 5) | |
18 F-FDG | |||
Positive–no. (%) | 7 (58) | 2 (22) | 5 (100) |
Negative–no. (%) | 5 (42) | 7 (78) | 0 |
SUVmax, Median (IQR) | 2.2 (1.6–4.3) | 1.4 (0.7–1.8) | 11.3 (10.1–17.1) |
18 F-FSPG | |||
Positive–no. (%) | 9 (75) | 3 (33) | 5 (100) |
Negative–no. (%) | 3 (25) | 6 (67) | 0 |
SUVmax, Median (IQR) | 1.2 (1–1.7) | 0.7 (0.4–1.0) | 8.5 (6.7–8.8) |
SUVmax–Maximum standardized uptake value
18F-FSPG SUVmax >1 and 18F-FDG SUVmax >2 defines a positive result